Search
John Castellani, President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America (PhRMA) and Ralph G. Neas, President and Chief Executive Officer, Generic Pharmaceutical Association (GPhA), took the dais together at the Partnership for Safe Medicines 2012 Interchange on September 28, 2012 to discuss the risks of counterfeits to patient safety.
In February and March 2012, the Food and Drug Administration announced fake cancer drugs had infiltrated the secure US drug supply chain. The investigation into who sold these drugs to US doctors in ongoing.
Seventy-six doctors in twenty-two states were contacted by the FDA because they may have purchased counterfeit Avastin from a “little-known drug wholesaler, Montana Healthcare Solutions,” reported the Wall Street Journal.
The Partnership for Safe Medicines’ 2012 Interchange on September 28th, 2012 at the National Press Club brought together researchers, patient advocates, law enforcement and industry to discuss the damage counterfeit medications and fake online pharmacies cause to Americans. “This year’s Interchange was our boldest, most ambitious effort to date,” said PSM President Dr. Marvin D. Shepherd. “By bringing together stakeholders…
Read More
Partnership for Safe Medicines 2012 Interchange PSM’s annual Interchange conference was held on September 28, 2012 at the National Press Club (Washington DC). The annual Interchange brings together policymakers, pharmaceutical manufacturers, patient advocates, law enforcement, healthcare professionals, and anti-counterfeiting companies to discuss the problem and solutions to the global scourge of pharmaceutical counterfeiting. Watch the archive on C-SPAN | Press…
Read More100 Countries Participate in Operation Pangea V’s Worldwide
Crackdown on Fake Pharmacies and Drugs
The Partnership for Safe Medicines (PSM) is extremely pleased with the conclusion of Operation Pangea V, a worldwide, coordinated sting operation targeting illegal online pharmacies that has yielded spectacular results.
Coordinated by INTERPOL, Pangea V ran from September 25 through October 2 and was a global effort involving the cooperation of law enforcement, customs, health officials and the private sector.
Read MoreFDA launches BeSafeRx, a national campaign to make online pharmacy shopping safer, warning consumers that 97% of pharmacies online don’t adhere to state and federal laws.
In a report carried by the Washington Post, FDA Commissioner Margaret Hamburg has announced a new consumer education campaign, aimed at protecting the American consumer from counterfeit drugs.
Read MoreDr. Margaret Hamburg, FDA Commissioner, delivering the keynote address at the 2012 Interchange. Image courtesy of C-SPAN.
Read MoreU.S. FDA Commissioner Hamburg Urges Physicians,
Patients to Only Purchase Medicines from Reliable Sources to
Better Protect Against Fake Drugs
Washington, D.C. (September 28, 2012) – The Partnership for Safe Medicines (PSM)
today convened leading domestic and international stakeholders in the fight
against counterfeit and substandard medicines, making a renewed commitment to
work together and implement new solutions to protect
patients worldwide. U.S. Food and Drug Administration Commissioner Dr. Margaret
Hamburg, in a keynote to the conference, highlighted new efforts her agency is
undertaking to reduce the threat and pledged the FDA’s ongoing support to
ensure a safe U.S. drug supply.
Dr. Margaret Hamburg, FDA Commissioner, addressed the Interchange in her keynote speech. Hamburg said that "We need to work together to stay ahead of the many avenues that criminals are finding that are putting the health and safety of American citizen's at risk." Calling them 21st Century snake oil peddlers, Hamburg said that FDA has a number of new tools…
Read More